bitBiome

bitBiome is a biotech company in Tokyo, Japan, founded in 2018. It has raised $28.8M across 3 rounds, most recently an Extension Round in May 2026.

The single-cell microbe company

Headquarters
Tokyo
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$28.8M
Last Round
Extension RoundMay 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

bitBiome is a Tokyo-based biotechnology company founded in 2018, spun out of Waseda University research by founder Masahito Hosokawa. The company has built proprietary microbial single-cell microfluidic sequencing technology (bit-MAP®) and a large microbial sequence database (bit-GEM) containing over 1.3 billion sequences. bitBiome offers three primary service lines: enzyme discovery and engineering, synthetic biology applications, and microbiome sequencing analysis. The company's technology unlocks the potential of previously unculturable microbes and serves pharmaceutical, food, materials, and life science customers. Partners include Ajinomoto, Tokyo Ohka Kogyo, and Twist Bioscience. The company employs approximately 45 people.

Summary

It lists 11–50 employees. It has raised $28.8M in total across 3 rounds, most recently a Extension Round in May 2026. Investors include IT-Farm, IQT and Kirin Health Innovation Fund.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundExtension RoundMay 2026

Sign up to see all 3 events

Funding: Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech, Genomics
ConvertibleTotal funding$1.2BFeb 2021
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series ETotal funding$853.3MJun 2026
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

bitBiome on Indexed.vc
<a href="https://indexed.vc/companies/bitbiome"><img src="https://indexed.vc/api/badge/company/bitbiome" alt="bitBiome on Indexed.vc" width="260" height="76" /></a>